{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:41:49Z","timestamp":1781880109474,"version":"3.54.5"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Scientific Research Fund of Wuhan Municipal Health Commission","award":["WG20D07"],"award-info":[{"award-number":["WG20D07"]}]},{"name":"Wuhan Municipal Bureau of Science and Technology","award":["2024040801020381"],"award-info":[{"award-number":["2024040801020381"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32220103001"],"award-info":[{"award-number":["32220103001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Key Laboratory of Microbiology in Genomic Modification & Editing and Application"},{"name":"Shenzhen Science and Technology Program","award":["ZDSYS20230626090759006"],"award-info":[{"award-number":["ZDSYS20230626090759006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Whole-genome sequencing (WGS) has limitations in clinical diagnostics due to host DNA interference and lower pathogen load in clinical samples compared to cultured isolates, which reduce the effective sequencing depth and compromise the detection of resistance-associated mutations. As our understanding of the relationship between genotypes and phenotypes improves, targeted next-generation sequencing (tNGS) is emerging as a promising tool for predicting drug resistance in Mycobacterium tuberculosis. This study aimed to evaluate the performance of nanopore targeted sequencing (NTS) in detecting drug resistance in Mycobacterium tuberculosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We employed NTS to assess the drug susceptibility of 105 M. tuberculosis isolates and 175 clinical samples to 15 antituberculosis (TB) drugs, using phenotypic drug susceptibility testing as the gold standard.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>For cultured isolates, the overall sensitivity of NTS for 15 anti-TB drugs was 90.2% (95% CI, 86.5\u201393.2%), specificity 95.6% (94.2\u201396.8%), positive predictive value (PPV) 86.8% (83.1\u201389.8%), negative predictive value (NPV) 96.9% (95.7\u201397.7%), and overall agreement 94.3% (93.0\u201395.5%). The Cohen Kappa was 0.847 (0.814\u20130.880). For direct clinical samples, the sensitivity was 93.2% (89.5\u201395.9%), specificity 98.6% (98.0\u201399.1%), PPV 89.9% (86.0\u201392.8%), NPV 99.1% (98.6\u201399.4%), and agreement 98.0% (97.3\u201398.5%), with a Cohen Kappa value of 0.904 (0.876\u20130.931). NTS demonstrated a limit of detection of 500\u2005copies\/mL and could detect 4% heteroresistance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>NTS is a rapid and efficient diagnostic tool that reliably predicts drug resistance and shows potential to support resistance profiling in the clinical setting.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/clinchem\/hvaf061","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T07:10:56Z","timestamp":1748329856000},"page":"908-919","source":"Crossref","is-referenced-by-count":3,"title":["Diagnosis of Drug-Resistant Tuberculosis: Rapid Evaluation of Drug Susceptibility with Nanopore Targeted Sequencing"],"prefix":"10.1093","volume":"71","author":[{"given":"Jun","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Wuhan Pulmonary Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijing","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Disease, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Wuhan Pulmonary Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Wuhan Pulmonary Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyi","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Wuhan Pulmonary Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Wuhan Pulmonary Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"R&D Department, Wuhan EasyDiagnosis Biomedicine Co., Ltd , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liao","sequence":"additional","affiliation":[{"name":"R&D Department, Wuhan EasyDiagnosis Biomedicine Co., Ltd , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengbin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Wuhan Pulmonary Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Wuhan Pulmonary Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Wuhan Pulmonary Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Disease, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University , Wuhan ,","place":["China"]},{"name":"Department of Burn and Plastic Surgery, Shenzhen Key Laboratory of Microbiology in Genomic Modification & Editing and Application, Shenzhen Institute of Translational Medicine, Shenzhen University Medical School, The First Affiliated Hospital of Shenzhen University , Shenzhen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Wuhan Pulmonary Hospital , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"2025080103015815900_hvaf061-B1","doi-asserted-by":"crossref","first-page":"2004077","DOI":"10.1183\/13993003.04077-2020","article-title":"Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics?","volume":"57","author":"Mohamed","year":"2021","journal-title":"Eur Respir J"},{"key":"2025080103015815900_hvaf061-B2","volume-title":"Global tuberculosis report 2024","author":"WHO","year":"2024"},{"key":"2025080103015815900_hvaf061-B3","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/S2666-5247(21)00044-6","article-title":"Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study","volume":"2","author":"Z\u00fcrcher","year":"2021","journal-title":"Lancet Microbe"},{"key":"2025080103015815900_hvaf061-B4","volume-title":"Guidelines for the programmatic management of drugresistant tuberculosis: emergency update 2008","author":"WHO","year":"2008"},{"key":"2025080103015815900_hvaf061-B5","volume-title":"The use of next-generation sequencing for the surveillance of drug-resistant tuberculosis: an implementation manual","author":"WHO","year":"2023"},{"key":"2025080103015815900_hvaf061-B6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S1473-3099(24)00263-9","article-title":"Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"24","author":"Schwab","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025080103015815900_hvaf061-B7","doi-asserted-by":"crossref","first-page":"e1002794","DOI":"10.1371\/journal.pmed.1002794","article-title":"Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: a performance, ease-of-use, and cost evaluation","volume":"16","author":"Colman","year":"2019","journal-title":"PLoS Med"},{"key":"2025080103015815900_hvaf061-B8","doi-asserted-by":"crossref","first-page":"106164","DOI":"10.1016\/j.jinf.2024.106164","article-title":"Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022\u201323","volume":"88","author":"Cane","year":"2024","journal-title":"J Infect"},{"key":"2025080103015815900_hvaf061-B9","doi-asserted-by":"crossref","first-page":"1206056","DOI":"10.3389\/fpubh.2023.1206056","article-title":"Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing","volume":"11","author":"Murphy","year":"2023","journal-title":"Front Public Health"},{"key":"2025080103015815900_hvaf061-B10","doi-asserted-by":"crossref","first-page":"e00646-21","DOI":"10.1128\/JCM.00646-21","article-title":"Nanopore sequencing for Mycobacterium tuberculosis: a critical review of the literature, new developments, and future opportunities","volume":"60","author":"Dippenaar","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2025080103015815900_hvaf061-B11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature16996","article-title":"Real-time, portable genome sequencing for Ebola surveillance","volume":"530","author":"Quick","year":"2016","journal-title":"Nature"},{"key":"2025080103015815900_hvaf061-B12","volume-title":"Performance standards for susceptibility testing of Mycobacteria, Nocardia spp., and other aerobic Actinomycetes","author":"CLSI","year":"2018"},{"key":"2025080103015815900_hvaf061-B13","volume-title":"Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis","author":"WHO","year":"2018"},{"key":"2025080103015815900_hvaf061-B14","volume-title":"Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex","author":"WHO","year":"2022"},{"key":"2025080103015815900_hvaf061-B15","volume-title":"Susceptibility testing of Mycobacteria, Nocardia spp., and other aerobic Actinomycetes","author":"CLSI","year":"2018","edition":"3rd Ed"},{"key":"2025080103015815900_hvaf061-B16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"2025080103015815900_hvaf061-B17","doi-asserted-by":"crossref","first-page":"e0257521","DOI":"10.1371\/journal.pone.0257521","article-title":"Sequencing DNA with nanopores: troubles and biases","volume":"16","author":"Delahaye","year":"2021","journal-title":"PLoS One"},{"key":"2025080103015815900_hvaf061-B18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/jac\/dkt535","article-title":"Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complex","volume":"69","author":"Feuerriegel","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2025080103015815900_hvaf061-B19","volume-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","author":"WHO","year":"2023","edition":"2nd Ed"},{"key":"2025080103015815900_hvaf061-B20","doi-asserted-by":"crossref","first-page":"731.e9","DOI":"10.1016\/j.cmi.2021.09.014","article-title":"Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China","volume":"28","author":"Liu","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025080103015815900_hvaf061-B21","doi-asserted-by":"crossref","first-page":"1701354","DOI":"10.1183\/13993003.01354-2017","article-title":"A standardised method for interpreting the association between mutations and phenotypic drug resistance inMycobacterium tuberculosis","volume":"50","author":"Miotto","year":"2017","journal-title":"Eur Respir J"},{"key":"2025080103015815900_hvaf061-B22","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.2147\/IDR.S368444","article-title":"Pyrazinamide resistance and pncA mutation profiles in multidrug resistant Mycobacterium tuberculosis","volume":"15","author":"Shi","year":"2022","journal-title":"Infect Drug Resist"},{"key":"2025080103015815900_hvaf061-B23","volume-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","author":"WHO","year":"2021"},{"key":"2025080103015815900_hvaf061-B24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12941-022-00537-z","article-title":"Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations","volume":"21","author":"Wang","year":"2022","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025080103015815900_hvaf061-B25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1473-3099(21)00452-7","article-title":"Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB\/XDR assay: a cross-sectional multicentre diagnostic accuracy study","volume":"22","author":"Penn-Nicholson","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025080103015815900_hvaf061-B26","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/jac\/dkaa136","article-title":"Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid","volume":"75","author":"Kadura","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2025080103015815900_hvaf061-B27","doi-asserted-by":"crossref","first-page":"e0153563","DOI":"10.1371\/journal.pone.0153563","article-title":"Discordance across phenotypic and molecular methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a low TB incidence country","volume":"11","author":"Manganelli","year":"2016","journal-title":"PLoS One"},{"key":"2025080103015815900_hvaf061-B28","doi-asserted-by":"crossref","first-page":"e20220261","DOI":"10.1590\/1678-4685-gmb-2022-0261","article-title":"Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line","volume":"46","author":"Rossini","year":"2023","journal-title":"Genet Mol Biol"},{"key":"2025080103015815900_hvaf061-B29","doi-asserted-by":"crossref","first-page":"MGM2-0014-2013","DOI":"10.1128\/microbiolspec.MGM2-0014-2013","article-title":"Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities","volume":"2","author":"Vilch\u00e8ze","year":"2014","journal-title":"Microbiol Spectr"},{"key":"2025080103015815900_hvaf061-B30","doi-asserted-by":"crossref","first-page":"MGM2-0036-2013","DOI":"10.1128\/microbiolspec.MGM2-0036-2013","article-title":"Molecular basis of drug resistance in Mycobacterium tuberculosis","volume":"2","author":"Cohen","year":"2014","journal-title":"Microbiol Spectr"},{"key":"2025080103015815900_hvaf061-B31","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.03695-14","article-title":"Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in Northern China from 2006 to 2012","volume":"59","author":"Zhang","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2025080103015815900_hvaf061-B32","doi-asserted-by":"crossref","first-page":"2276339","DOI":"10.1080\/22221751.2023.2276339","article-title":"Association between mutations in a thyX-hsdS.1 region and para-aminosalicylic acid resistance in Mycobacterium tuberculosis clinical isolates","volume":"12","author":"Zeng","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"2025080103015815900_hvaf061-B33","doi-asserted-by":"crossref","first-page":"e102135","DOI":"10.1371\/journal.pone.0102135","article-title":"Acquired resistance of Mycobacterium tuberculosis to bedaquiline","volume":"9","author":"Andries","year":"2014","journal-title":"PLoS One"},{"key":"2025080103015815900_hvaf061-B34","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/S2666-5247(20)30031-8","article-title":"Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in Southern Africa: a phenotypic and phylogenetic analysis","volume":"1","author":"Nimmo","year":"2020","journal-title":"Lancet Microbe"},{"key":"2025080103015815900_hvaf061-B35","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1128\/AAC.00753-16","article-title":"Mutations in pepQ confer low-level resistance to bedaquiline and clofazimine in Mycobacterium tuberculosis","volume":"60","author":"Almeida","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2025080103015815900_hvaf061-B36","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/jac\/dkx094","article-title":"Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region","volume":"72","author":"Zimenkov","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2025080103015815900_hvaf061-B37","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S2666-5247(23)00002-2","article-title":"Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis","volume":"4","author":"Sonnenkalb","year":"2023","journal-title":"Lancet Microbe"},{"key":"2025080103015815900_hvaf061-B38","doi-asserted-by":"crossref","first-page":"e0116421","DOI":"10.1128\/AAC.01164-21","article-title":"Role of epistasis in amikacin, kanamycin, bedaquiline, and clofazimine resistance in Mycobacterium tuberculosis complex","volume":"65","author":"Vargas","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2025080103015815900_hvaf061-B39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jgar.2023.05.001","article-title":"Evaluation of genetic mutations associated with phenotypic resistance to fluoroquinolones, bedaquiline, and linezolid in clinical Mycobacterium tuberculosis: a systematic review and meta-analysis","volume":"34","author":"An","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"key":"2025080103015815900_hvaf061-B40","doi-asserted-by":"crossref","first-page":"655653","DOI":"10.3389\/fmicb.2021.655653","article-title":"Low rate of acquired linezolid resistance in multidrug-resistant tuberculosis treated with bedaquiline-linezolid combination","volume":"12","author":"Du","year":"2021","journal-title":"Front Microbiol"},{"key":"2025080103015815900_hvaf061-B41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4103\/ijmy.ijmy_139_24","article-title":"Agreement between phenotypically detected linezolid resistance and mutations in rrl and rplC genes of Mycobacterium tuberculosis isolates using nanopore sequencing","volume":"13","author":"Sengupta","year":"2024","journal-title":"Int J Mycobacteriol"},{"key":"2025080103015815900_hvaf061-B42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/antibiotics9030133","article-title":"Whole genome sequencing for the analysis of drug-resistant strains of Mycobacterium tuberculosis: a systematic review for bedaquiline and delamanid","volume":"9","author":"Nieto Ramirez","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"2025080103015815900_hvaf061-B43","doi-asserted-by":"crossref","first-page":"e00900-17","DOI":"10.1128\/AAC.00900-17","article-title":"In vitro drug susceptibility of bedaquiline, delamanid, linezolid, clofazimine, moxifloxacin, and gatifloxacin against extensively drug-resistant tuberculosis in Beijing, China","volume":"61","author":"Pang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2025080103015815900_hvaf061-B44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jinf.2021.02.004","article-title":"Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: a subsequent study of a national survey","volume":"82","author":"Wang","year":"2021","journal-title":"J Infect"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/71\/8\/908\/63370719\/hvaf061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/71\/8\/908\/63370719\/hvaf061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:02:09Z","timestamp":1754031729000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/71\/8\/908\/8151381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,5,27]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvaf061","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,5,27]]}}}